Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,168,198 | 5,111,267 | 2,150,799 | 6,726,709 | 4,625,358 |
| Depreciation Amortization | -426,294 | -1,204,914 | 248,514 | 2,980,285 | 3,048,223 |
| Accounts receivable | N/A | N/A | N/A | -40,861 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 335,825 | N/A |
| Other Working Capital | 133,055 | 961,698 | -1,019,676 | 453,300 | -1,637,557 |
| Other Operating Activity | -950,764 | -245,698 | -143,472 | -214,517 | -404,456 |
| Operating Cash Flow | $5,924,195 | $4,622,353 | $1,236,165 | $10,240,740 | $5,631,568 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,535,657 | 3,304,517 | 24,339 | -240,057 | -230,590 |
| PPE Investments | -874,549 | -506,287 | -244,671 | -1,493,973 | -861,937 |
| Net Acquisitions | 313,907 | 286,648 | 187,026 | -4,441,059 | -4,377,505 |
| Purchase Of Investment | -1,292 | -1,241 | -1,281 | N/A | -7,399 |
| Purchase Sale Intangibles | -58,131 | 384,679 | -43,554 | -630,789 | -647,378 |
| Other Investing Activity | -114,971 | 357,379 | -39,711 | -661,433 | -668,341 |
| Investing Cash Flow | $2,858,753 | $3,441,016 | $-74,298 | $-6,836,522 | $-6,145,771 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 3,952,006 | 5,363,985 |
| Debt Issued | 3,013,769 | 2,921,079 | N/A | 6,121,458 | 5,946,008 |
| Common Stock Issued | 36,170 | 32,263 | 29,463 | 65,122 | 50,557 |
| Dividend Paid | -3,915,446 | -2,587,277 | -1,205,421 | -5,047,586 | -3,714,097 |
| Other Financing Activity | -9,413,343 | -4,933,818 | -171,654 | -7,440,496 | -6,513,234 |
| Financing Cash Flow | $-10,278,850 | $-4,567,753 | $-1,347,612 | $-2,349,496 | $1,133,219 |
| Exchange Rate Effect | -21,961 | 34,745 | 53,802 | -104,706 | 24,662 |
| Beginning Cash Position | 6,240,686 | 5,994,788 | 6,188,511 | 5,218,690 | 5,039,680 |
| End Cash Position | 4,722,821 | 9,525,148 | 6,056,568 | 6,168,704 | 5,683,358 |
| Net Cash Flow | $-1,517,865 | $3,530,361 | $-131,943 | $950,014 | $643,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,924,195 | 4,622,353 | 1,236,165 | 10,240,740 | 5,631,568 |
| Capital Expenditure | -919,762 | -521,178 | -252,357 | -1,615,278 | -967,984 |
| Free Cash Flow | 5,004,433 | 4,101,175 | 983,808 | 8,625,462 | 4,663,585 |